Counterfeit  medicines  have  become  a  topic  of  concern  in  many  parts  of  the  ; The  EU  has  introduced  the  Falsified  Medicines  Directive,  which  is  here  to  help  prevent  prescription  drugs  from  being  misbranded,  sold  after  expiry,  counterfeited,  diverted,  stolen,  and  ; All manufacturers,  wholesalers,  re-packagers,  OEMs,  and  pharmacies  must  adapt  to  the  new regulatory landscape. There is no doubt that serialisation will change the way companies are distributing their products. Packaging, commercial relation-ships with customers, regulatory activities, and the way they are managing their data will be heavily impacted as well. It will also trigger a wave of challenges that companies will be facing: In their manufacturing, operations, and supply chain management processes. This is the exact reason we decided to run this event and provide a platform for an essential dialog between pharma companies, CMOs, CPOs, and CDMOs. Global pharma companies will learn how to build enterprise-wide strategies and technology infrastructures to handle the markets in a consistent way. Contractors will have an opportunity to discuss how to handle different requirements from different customers. The  event  will  be  covering  a  range  of  real  life  case  studies:  starting  from  the  impact  serialisation  has  on  company’s  management  processes,  how  to  find  a  qualified  supplier,  how  to  fund  the  changes  in  packaging  lines,  and  even  involving  IT  matters. Knowledge sharing provided at this event will ensure that all industry players are ready to successfully face regulatory deadlines.